TELO (Telomir Pharmaceuticals, Inc. Common Stock) Stock Financials & Earnings

TELOTelomir Pharmaceuticals, Inc. Common Stock

Mkt Cap$46M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$11M

EPS (TTM)-$0.38

Free Cash Flow (TTM)-$3M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q4 22	$0	$0	-$487K
Q1 23	$0	$0	-$483K
Q2 23	$0	$0	-$1M
Q3 23	$0	$0	-$954K
Q4 23	$0	$0	-$1M
Q1 24	$0	$0	-$2M
Q2 24	$0	$0	-$1M
Q3 24	$0	$0	-$6M
Q4 24	$0	$0	-$3M
Q1 25	$0	$0	-$2M
Q2 25	$0	$0	-$5M
Q3 25	$0	$0	-$1M

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q4 22	$477K	$10K	—
Q1 23	$440K	$43K	—
Q2 23	$668K	$60K	—
Q3 23	$263K	—	$692K
Q4 23	$204K	—	$875K
Q1 24	$804K	$742K	—
Q2 24	$595K	$880K	—
Q3 24	$627K	—	$5M
Q4 24	$269K	—	$3M
Q1 25	$337K	—	$2M
Q2 25	$43K	$5M	—
Q3 25	$760K	$387K	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$1K	$0	$1K
Q1 23	$0	$3K	$3K
Q2 23	$15K	$0	$15K
Q3 23	$2K	$0	$2K
Q4 23	$1K	$0	$1K
Q1 24	$3M	$0	$3M
Q2 24	$2M	$0	$2M
Q3 24	$835K	$0	$835K
Q4 24	$1M	$0	$1M
Q1 25	$403K	$0	$403K
Q2 25	$754K	$0	$754K
Q3 25	$7M	$0	$7M

Shares Outstanding

Revenue Per Employee

Revenue / Employee